← All stocks

Faeth Therapeutics, Inc.

FTH Net buying
CIK 0001829802 #2705 in the set updated 17 Sep 2026
Bought (120 mo)
$10.80M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.40M
$0.00 on a plan · $82.48K straight out of an exercise
Sold at will
$8.32M
44 of 51 sales
Net
+$2.40M
+$2.48M against sales at will

By person

20 insiders · 229 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Apeiron Investment Group Ltd. entity
10% owner
$3.54K (2)
$5.44M (2)
−$5.43M
0
$0.00
−100.0%
Cambrian BioPharma Inc entity
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
130,142
$3.15M
Peyer James
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
5,097,528
$123.46M
+34.9%
STEPHENSON BRIAN C
Chief Financial Officer
$1.13M (22)
+$1.13M
46,688
$1.13M
Pierce Robert Hamilton
Chief R&D Officer
$685.96K (4)
−$685.96K
21,000
$508.62K
−78.1%
MILLENNIUM MANAGEMENT LLC entity
10% owner
$1.34M (26)
$704.45K (25)
+$637.27K
133,986
$3.25M
+21.7%
RICKS THOMAS G
Director
$249.60K (2)
+$249.60K
652,470
$15.80M
+116.2%
Parikh Anand Kiran
President and CEO
$55.45K (1)
+$55.45K
817,699
$19.80M
Celebi John
PRESIDENT AND CEO
$425.00 (1)
+$425.00
105,862
$2.56M
+936.8%
H&S INVESTMENTS I LP entity
10% owner
4,425,998
$107.20M
+6,798%
Colgan Erin
CHIEF FINANCIAL OFFICER
67,462
$1.63M
+596.5%
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
59,794
$1.45M
+80.2%
Hahn Stephen M.
Director
44,763
$1.08M
Gallagher Patrick Stephen
Chief Business Officer
43,515
$1.05M
+363.7%
Holmen Bob
Director
25,598
$619.98K
+53.6%
RINGO WILLIAM R
Director
23,399
$566.72K
Humer Kristian
Director
8,932
$216.33K
English Jessie
Director
8,932
$216.33K
Vojta Deneen
Director
8,932
$216.33K
Broder Samuel
Director
8,932
$216.33K

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Parikh Anand Kiran
22 Jun 2026
President and CEO
Exercised, kept
8,213
$1.16
$9.53K
Parikh Anand Kiran
22 Jun 2026
President and CEO
Exercised, kept
45,252
$1.16
$52.49K

What was left out

Form 4 filings counted 197
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 13,983,920
Sales filed before the plan box existed 4
History held since 5 Feb 2021